NCT00475254

Brief Summary

Retinitis pigmentosa (RP) patients experience a slowly progressive, unpredictable loss of vision which eventually leads to bare or no light perception, posing a continuous threat to patients' independence. Negative psychological states such as distress, sleepiness, anxiety and depression are common in RP patients due to the nature of this chronic, disabling disease. Psychophysical vision measures are more variable in legally blind RP subjects than in normally sighted individuals, and RP patients indicate that variations in vision are often related to stress. The primary goal of this research is to examine the vision fluctuations within and between days among RP patients using vision tests self-administered by patients through their home computers, and determine associations with factors such as perceived stress, mood states, sleepiness, or light exposure. The administration of questionnaires will allow us to gain some insight into which underlying psychological factors impact certain vision measures, allowing the design of future interventional research to attempt to reduce such factors. The aims of many future treatment clinical trials for RP will be to improve vision and/or reduce the rate of vision loss; thus the sources that lead to increased variability of vision need to be identified and alleviated to enable precise evaluation of interventions and improve patients' quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2007

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2007

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 21, 2007

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2007

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

April 6, 2011

Status Verified

August 1, 2008

Enrollment Period

3.7 years

First QC Date

May 16, 2007

Last Update Submit

April 5, 2011

Conditions

Keywords

Retinitis Pigmentosastresssleepinesslow visionmind-body

Outcome Measures

Primary Outcomes (1)

  • Vision test reliability across multiple test administrations in relation to psychological and external factors

    2-3 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals with a confirmed diagnosis of retinitis pigmentosa

You may qualify if:

  • Patients with diagnosed retinitis pigmentosa

You may not qualify if:

  • Very severe vision loss (i.e., light perception only) who may have difficulty performing the vision tests with their home computers
  • Unable to use a PC (Personal Computer)
  • Non-English speaking
  • Unable to communicate experiences
  • Out of town for more than one week during a 2 month period when taking the PC-based tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins WiImer Eye Insitute's Lions Vision Center

Baltimore, Maryland, 21205, United States

Location

Related Links

MeSH Terms

Conditions

Retinitis PigmentosaSleepinessVision, Low

Condition Hierarchy (Ancestors)

Eye Diseases, HereditaryEye DiseasesRetinal DystrophiesRetinal DegenerationRetinal DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSigns and SymptomsPathological Conditions, Signs and SymptomsVision DisordersSensation DisordersNeurologic ManifestationsNervous System Diseases

Study Officials

  • Ava K. Bittner, O.D., Ph.D.

    Johns Hopkins Wilmer Eye Institute

    PRINCIPAL INVESTIGATOR
  • Maureen George, Ph.D.

    Johns Hopkins School of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 16, 2007

First Posted

May 21, 2007

Study Start

August 1, 2007

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

April 6, 2011

Record last verified: 2008-08

Locations